NCT03672513 is a NA clinical trial of Zinc Supplement in Menopause, sponsored by Universidad de Granada.

Who is sponsoring NCT03672513?

NCT03672513 is sponsored by Universidad de Granada.

What drugs are being tested in NCT03672513?

Interventions in NCT03672513: Placebo Comparator, Zinc Supplement, Magnesium supplement.

What condition does NCT03672513 study?

NCT03672513 studies Menopause, Nutritional Intervention, Bone Diseases.

Is NCT03672513 still recruiting?

NCT03672513 is currently completed. Last updated 14 September 2018.

Last reviewed 2018-09-14 · How we verify

NCT03672513

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause

Completed NA Last updated 14 September 2018

What this trial tests

NA trial testing Placebo Comparator in Menopause in 78 participants. Completed in 8 September 2018.

Timeline

8 September 2016

Primary endpoint
1 November 2017

8 September 2018

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	78
Start date	8 September 2016
Primary completion	1 November 2017
Estimated completion	8 September 2018
Sites	1 location across Spain

Drugs / interventions tested

Placebo Comparator
Zinc Supplement
Magnesium supplement

Conditions studied

Menopause — all drugs for Menopause →
Nutritional Intervention — all drugs for Nutritional Intervention →
Bone Diseases — all drugs for Bone Diseases →

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 44 to 76, female only, with Menopause or Nutritional Intervention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a 8-week, double-blinded, placebo-controlled, randomized intervention trial to investigate the effects of Mg and Zn supplementation on antioxidant status and bone hormonal parameters. Participants were randomly assigned to one of three treatment groups: Placebo group (PbG: 25 women); Magnesium Group - 500 mg/day of Mg (MgG: 27 women); Zinc Group - 50 mg/day of Zn (ZnG: 26 women).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Response of Vitamin D after Magnesium Intervention in a Postmenopausal Population from the Province of Granada, Spain.
Vázquez-Lorente H, Herrera-Quintana L, Molina-López J, Gamarra-Morales Y, et al · · 2020 · cited 19× · PMID 32751522 · DOI 10.3390/nu12082283
Erythrocyte Zn concentration and antioxidant response after supplementation with Zn in a postmenopausal population. A double-blind randomized trial.
Vázquez-Lorente H, Molina-López J, Herrera-Quintana L, Gamarra-Morales Y, et al · · 2022 · cited 6× · PMID 35278643 · DOI 10.1016/j.exger.2022.111766

Verify or expand the search:

Other trials of Zinc Supplement

Trials testing the same drug.

NCT05465434 — Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti- · Phase 3 · completed

Other recruiting trials for Menopause

Currently open trials in the same condition.

NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03672513 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 14 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03672513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing